Our team, Johns Hopkins Medicine and @HopkinsNeurons are excited to announce the opening of applications for the #FrancisSCollinsScholars program in #NF Clinical and Translational Research for early-stage scientists who want to be part of the cure! Apply here: bit.ly/3X2yKoM

The #NF1 Nerve Sheath Tumor Biomarker Development Symposium brought together creative thinkers and powerful do-ers to identify the most promising liquid, tissue, imaging and digital records markers to inform therapeutics for #NF1 tumors. Learn more: bit.ly/3Ra01BQ

Loved having Francis Collins Scholar, Laura Fertitta visit Johns Hopkins on her NF Center Tour. Laura met with our NF1 team and gave a great talk on "Management, and clinical and translational research on Neurofibromatosis 1: a French experience."

Kudos to the Johns Hopkins Neurology and Neurosurgery Program. Ranked 5th in the nation by U.S. News & World Report Best Hospitals Rankings. Well-deserved recognition! Johns Hopkins Medicine

Congrats to Dr. Helena Mazuelas Gallego, Ph.D., and the Serra team for winning 1st place in the Basic Science Poster Competition at the Global NF Children's Tumor Fdn conference! NTAP is proud to support their research on NF1-associated tumors’ development and therapies/management.

NTAP is #HIRING! If you are a recent grad or have Physician Asst. / Nurse Practitioner entry-level experience, apply to this position on our #NF team that sees patients in the clinic and trials. Physician Asst: bit.ly/3LIXfQZ Nurse Practitioner: bit.ly/4c3bZ7W

I had the honor and pleasure of sharing my thoughts on the research and care for children with #ADHD, #Autisem and #RASopathies, specificaly #NF1 and #Noonan Syndrome. Children's Tumor Fdn; Neurofibromatosis Therapeutic Acceleration Program; Stanford Medicine

Great talk given by Carlos Romo, MD César de Tassis Filho ([email protected]) Global Conference on current therapies and ongoing research to improve cNF strategies for people with NF1. We are making great strides. Johns Hopkins Medicine

#NF researchers, are you ready for Neurofibromatosis Young Investigators Forum this Dec? We've partnered with CEC Oncology to help you showcase your research, connect with other Young Investigators, & catalyze your career. Submit your abstract! ➡️ ce.ceconcepts.com/NFYIFsubmit   #NF #EndNF #MedTwitter #MedEd

Congrats! Proud to support Soragni:Lab! The lack of therapies for #cNF stems from the complexity of their cell composition. Dr. Soragni & team developed a high-throughput organoid screening platform that rapidly tests 3D tumor organoids for drug efficacy. Great work! #NF1

Apply today! Up to $25M available in funding for NF-related research. Exciting opportunities for scientists across all disciplines & areas of biomedical focus. Don't miss this opportunity! Letter of Intent due 9/12/2024. cdmrp.health.mil/nfrp

Have you submitted your abstract for Neurofibromatosis Young Investigators Forum this Dec? Don’t miss this opportunity to showcase your research & connect with other Young Investigators to learn about the latest in #NF research. Submit your abstract! ➡️ ce.ceconcepts.com/NFYIFsubmit #NF #EndNF #MedTwitter #NFYIF24

NTAP was proud to support a publication from one of our #FrancisSCollinsScholars, Dr. Taylor Sundby, MD 🧬, in AACR’s Clinical Cancer Research journal. The article details a cfDNA fragmentomic approach to distinguish between forms of PNST in #NF1. Read more: bit.ly/4gc6FSU #neurofibromatosis

Incredible work by the Francis S. Collins Scholars Program Summer Interns who dove deep into NF1 research. Huge thanks to Angela Hirbe, Tamar Green & Shruti Garg for mentoring these talented young scientists. Wishing them all the best in their research journey! #EndNF

Proud to support Tamar Green and her team's research!

Need help explaining what NF is—and what it isn’t—especially after seeing it mentioned in movies or on TV? Check out this excellent resource from the Children's Tumor Foundation to clear up misconceptions and provide accurate information. ctf.org/understanding-…

NF1 affects 1/2,500 people w/a wide range of manifestations. People w/NF1 often face stigma & symptoms remain w/o effective treatments. Neurofibromatosis Therapeutic Acceleration Program accelerates meaningful therapies for NF1 while learning life lessons from the talented @AdamPearson. A Different Man #makenfvisible

Dr. Riccardi was consistently present for the Francis Collins Scholars community. His dedication to NF1 research and mentoring the next generation of NF specialists was unparalleled. He is fondly remembered and greatly missed.